These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7897127)

  • 1. Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Ellis SG; Cowley MJ; Whitlow PL; Vandormael M; Lincoff AM; DiSciascio G; Dean LS; Topol EJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1137-42. PubMed ID: 7897127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center.
    Halon DA; Merdler A; Flugelman MY; Shifroni G; Khader N; Shiran A; Shahla J; Lewis BS
    Am J Cardiol; 1998 Sep; 82(5):547-53. PubMed ID: 9732877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).
    Bourassa MG; Kip KE; Jacobs AK; Jones RH; Sopko G; Rosen AD; Sharaf BL; Schwartz L; Chaitman BR; Alderman EL; Holmes DR; Roubin GS; Detre KM; Frye RL
    J Am Coll Cardiol; 1999 May; 33(6):1627-36. PubMed ID: 10334434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.
    Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO
    Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).
    Rodriguez A; Mele E; Peyregne E; Bullon F; Perez-Baliño N; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1996 Apr; 27(5):1178-84. PubMed ID: 8609339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%.
    O'Keefe JH; Allan JJ; McCallister BD; McConahay DR; Vacek JL; Piehler JM; Ligon R; Hartzler GO
    Am J Cardiol; 1993 Apr; 71(11):897-901. PubMed ID: 8465778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized, multicenter comparison of laser-facilitated balloon angioplasty versus stand-alone balloon angioplasty in patients with obstructive coronary artery disease. The Laser Angioplasty Versus Angioplasty (LAVA) Trial Investigators.
    Stone GW; de Marchena E; Dageforde D; Foschi A; Muhlestein JB; McIvor M; Rizik D; Vanderlaan R; McDonnell J
    J Am Coll Cardiol; 1997 Dec; 30(7):1714-21. PubMed ID: 9385898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
    Ellis SG; Vandormael MG; Cowley MJ; DiSciascio G; Deligonul U; Topol EJ; Bulle TM
    Circulation; 1990 Oct; 82(4):1193-202. PubMed ID: 2401060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.
    Stein B; Weintraub WS; Gebhart SP; Cohen-Bernstein CL; Grosswald R; Liberman HA; Douglas JS; Morris DC; King SB
    Circulation; 1995 Feb; 91(4):979-89. PubMed ID: 7850985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?
    Bell MR; Bailey KR; Reeder GS; Lapeyre AC; Holmes DR
    J Am Coll Cardiol; 1990 Sep; 16(3):553-62. PubMed ID: 2387928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
    Bentivoglio LG; Detre K; Yeh W; Williams DO; Kelsey SF; Faxon DP
    J Am Coll Cardiol; 1994 Nov; 24(5):1195-206. PubMed ID: 7930239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser-assisted coronary angioplasty in patients with severely depressed left ventricular function: quantitative coronary angiography and clinical results.
    Topaz O; Rozenbaum EA; Luxenberg MG; Schumacher A
    J Interv Cardiol; 1995 Dec; 8(6):661-9. PubMed ID: 10159757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year follow-up of percutaneous transluminal coronary angioplasty for proximal left anterior descending coronary artery stenosis in 351 patients.
    Ten Berg JM; Gin MT; Ernst SM; Kelder JC; Suttorp MJ; Mast EG; Bal E; Plokker HW
    J Am Coll Cardiol; 1996 Jul; 28(1):82-8. PubMed ID: 8752798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary angioplasty in elderly patients].
    Liistro F; Colombo A
    Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina.
    Morrison DA; Crowley ST; Veerakul G; Barbiere CC; Grover F; Sacks J
    J Am Coll Cardiol; 1994 Apr; 23(5):1066-70. PubMed ID: 8144769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.